193 related articles for article (PubMed ID: 20045984)
1. Inhibitory effects of Kampo medicine on human UGT2B7 activity.
Nakagawa N; Katoh M; Yoshioka Y; Nakajima M; Yokoi T
Drug Metab Pharmacokinet; 2009; 24(6):490-9. PubMed ID: 20045984
[TBL] [Abstract][Full Text] [Related]
2. Effects of Japanese herbal medicine, Kampo, on human UGT1A1 activity.
Katoh M; Yoshioka Y; Nakagawa N; Yokoi T
Drug Metab Pharmacokinet; 2009; 24(3):226-34. PubMed ID: 19571434
[TBL] [Abstract][Full Text] [Related]
3. Effects of Kampo extracts on drug metabolism in rat liver microsomes: Rhei Rhizoma extract and Glycyrrhizae Radix extract inhibit drug oxidation.
Hasegawa A; Kawaguchi Y; Nakasa H; Nakamura H; Ohmori S; Ishii I; Kitada M
Jpn J Pharmacol; 2002 Jun; 89(2):164-70. PubMed ID: 12120759
[TBL] [Abstract][Full Text] [Related]
4. Glucuronidation of the antiretroviral drug efavirenz by UGT2B7 and an in vitro investigation of drug-drug interaction with zidovudine.
Bélanger AS; Caron P; Harvey M; Zimmerman PA; Mehlotra RK; Guillemette C
Drug Metab Dispos; 2009 Sep; 37(9):1793-6. PubMed ID: 19487252
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of 3'-azido-3'-deoxythymidine, morphine, and codeine as probe substrates for UDP-glucuronosyltransferase 2B7 (UGT2B7) in human liver microsomes: specificity and influence of the UGT2B7*2 polymorphism.
Court MH; Krishnaswamy S; Hao Q; Duan SX; Patten CJ; Von Moltke LL; Greenblatt DJ
Drug Metab Dispos; 2003 Sep; 31(9):1125-33. PubMed ID: 12920168
[TBL] [Abstract][Full Text] [Related]
6. Predominant contribution of UDP-glucuronosyltransferase 2B7 in the glucuronidation of racemic flurbiprofen in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Jul; 35(7):1182-7. PubMed ID: 17446261
[TBL] [Abstract][Full Text] [Related]
7. Warfarin is an effective modifier of multiple UDP-glucuronosyltransferase enzymes: evaluation of its potential to alter the pharmacokinetics of zidovudine.
Sun H; Zhang T; Wu Z; Wu B
J Pharm Sci; 2015 Jan; 104(1):244-56. PubMed ID: 25393417
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of UDP-glucuronosyltransferase by aglycons of natural glucuronides in kampo medicines using SN-38 as a substrate.
Yokoi T; Narita M; Nagai E; Hagiwara H; Aburada M; Kamataki T
Jpn J Cancer Res; 1995 Oct; 86(10):985-9. PubMed ID: 7493919
[TBL] [Abstract][Full Text] [Related]
9. Altered AZT (3'-azido-3'-deoxythymidine) glucuronidation kinetics in liver microsomes as an explanation for underprediction of in vivo clearance: comparison to hepatocytes and effect of incubation environment.
Engtrakul JJ; Foti RS; Strelevitz TJ; Fisher MB
Drug Metab Dispos; 2005 Nov; 33(11):1621-7. PubMed ID: 16049128
[TBL] [Abstract][Full Text] [Related]
10. Interactions between crude drug extracts used in Japanese traditional Kampo medicines and organic anion-transporting polypeptide 2B1.
Iijima R; Watanabe T; Ishiuchi K; Matsumoto T; Watanabe J; Makino T
J Ethnopharmacol; 2018 Mar; 214():153-159. PubMed ID: 29248449
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of UDP-glucuronosyltransferase 2b7-catalyzed morphine glucuronidation by ketoconazole: dual mechanisms involving a novel noncompetitive mode.
Takeda S; Kitajima Y; Ishii Y; Nishimura Y; Mackenzie PI; Oguri K; Yamada H
Drug Metab Dispos; 2006 Aug; 34(8):1277-82. PubMed ID: 16679387
[TBL] [Abstract][Full Text] [Related]
12. Identification of human UGT2B7 as the major isoform involved in the O-glucuronidation of chloramphenicol.
Chen M; LeDuc B; Kerr S; Howe D; Williams DA
Drug Metab Dispos; 2010 Mar; 38(3):368-75. PubMed ID: 20008037
[TBL] [Abstract][Full Text] [Related]
13. Quantitative prediction of in vivo inhibitory interactions involving glucuronidated drugs from in vitro data: the effect of fluconazole on zidovudine glucuronidation.
Uchaipichat V; Winner LK; Mackenzie PI; Elliot DJ; Williams JA; Miners JO
Br J Clin Pharmacol; 2006 Apr; 61(4):427-39. PubMed ID: 16542204
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of UGT2B7 Enzyme Activity in Human and Rat Liver Microsomes by Herbal Constituents.
Abdullah NH; Ismail S
Molecules; 2018 Oct; 23(10):. PubMed ID: 30347696
[TBL] [Abstract][Full Text] [Related]
15. 3'-azido-3'-deoxythimidine (AZT) is glucuronidated by human UDP-glucuronosyltransferase 2B7 (UGT2B7).
Barbier O; Turgeon D; Girard C; Green MD; Tephly TR; Hum DW; Bélanger A
Drug Metab Dispos; 2000 May; 28(5):497-502. PubMed ID: 10772627
[TBL] [Abstract][Full Text] [Related]
16. Human UGT2B7 is the major isoform responsible for the glucuronidation of clopidogrel carboxylate.
Ji JZ; Huang BB; Gu TT; Tai T; Zhou H; Jia YM; Mi QY; Zhang MR; Xie HG
Biopharm Drug Dispos; 2018 Feb; 39(2):88-98. PubMed ID: 29240983
[TBL] [Abstract][Full Text] [Related]
17. The UDP-glucuronosyltransferase 2B7 isozyme is responsible for gemfibrozil glucuronidation in the human liver.
Mano Y; Usui T; Kamimura H
Drug Metab Dispos; 2007 Nov; 35(11):2040-4. PubMed ID: 17670842
[TBL] [Abstract][Full Text] [Related]
18. Inhibitory potential of nonsteroidal anti-inflammatory drugs on UDP-glucuronosyltransferase 2B7 in human liver microsomes.
Mano Y; Usui T; Kamimura H
Eur J Clin Pharmacol; 2007 Feb; 63(2):211-6. PubMed ID: 17200831
[TBL] [Abstract][Full Text] [Related]
19. Identification of human UDP-glucuronosyltransferase isoform(s) responsible for the glucuronidation of 2-(4-chlorophenyl)- 5-(2-furyl)-4-oxazoleacetic acid (TA-1801A).
Kaji H; Kume T
Drug Metab Pharmacokinet; 2005 Jun; 20(3):212-8. PubMed ID: 15988124
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of morphine glucuronidation in the liver microsomes of rats and humans by monoterpenoid alcohols.
Ishii Y; Iida N; Miyauchi Y; Mackenzie PI; Yamada H
Biol Pharm Bull; 2012; 35(10):1811-7. PubMed ID: 22878261
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
